Work

A Phase I Study of Vorinostat (V) in Combination with Rituximab (R), Ifosphamide, Carboplatin, and Etoposide (ICE) for Patients with Relapsed or Refractory Lymphoid Malignancies or Untreated T- or Mantle Cell Lymphoma.

Year: 2009

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v114.22.3696.3696

Authors: Lihua E. Budde, Michelle M. Zhang, Andrei R. Shustov, John M. Pagel, Thomas A. Warr, Tara L Chen, George R. Oliveira, Ted Gooley, Ajay K. Gopal

Institutions: University of Washington, Fred Hutch Cancer Center, Valley Medical Center, Seattle Cancer Care Alliance

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2556767910

FWCI: 0.933

Cites:

Cited by: 4

Related to: 10